An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage for insulin.

HB 305 requires health insurance policies to cover insulin, directly affecting people with diabetes who rely on this medication. It amends the 1921 Insurance Company Law to mandate that casualty insurance plans include insulin coverage without excessive cost-sharing. The key provision eliminates gaps where insulin might previously have been excluded or subject to high out-of-pocket costs. This policy change applies to all insurers offering casualty coverage under the amended law. The bill is currently pending before the Insurance committee.